Trials / Completed
CompletedNCT02470390
Open Label Crossover Study Pharmacokinetics (PK) Study in Healthy Volunteers Receiving Various Forms of Fentanyl
An Open-Label Single-Dose Crossover Study Comparing the Plasma and Cerebrospinal Fluid Pharmacokinetics and Bioavailability of Fentanyl Delivered Intranasally Versus Sublingually Versus Intravenously in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Depomed · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
A partially randomized, open-label, 3-way crossover, single-center, systemic and CSF PK and bioavailability study in healthy volunteers.
Detailed description
An Open-Label Single-Dose Crossover Study Comparing the Plasma and Cerebrospinal Fluid Pharmacokinetics and Bioavailability of Fentanyl Delivered Intranasally Versus Sublingually Versus Intravenously in Healthy Volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fentanyl | Lazanda (nasal spray), Subsys (sub-lingual) and intravenous fentanyl |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2015-01-01
- Completion
- 2015-04-01
- First posted
- 2015-06-12
- Last updated
- 2018-03-16
- Results posted
- 2018-03-16
Source: ClinicalTrials.gov record NCT02470390. Inclusion in this directory is not an endorsement.